@article{3078672,
    title = "Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma",
    author = "Papageorgiou, S.G. and Thomopoulos, T.P. and Spathis, A. and Bouchla, A. and Glezou, I. and Stavroulaki, G. and Gkontopoulos, K. and Bazani, E. and Foukas, P.G. and Pappa, V.",
    journal = "Journal of Hematology & Oncology",
    year = "2019",
    volume = "37",
    number = "5",
    pages = "634-637",
    publisher = "John Wiley and Sons Ltd",
    issn = "1756-8722",
    doi = "10.1002/hon.2685",
    keywords = "lactate dehydrogenase;  rituximab, adult;  bone marrow;  cancer prognosis;  cancer staging;  diffuse large B cell lymphoma;  disease predisposition;  event free survival;  female;  human;  International Prognostic Index;  lactate dehydrogenase blood level;  Letter;  major clinical study;  male;  middle aged;  monoclonal immunoglobulinemia;  priority journal;  complication;  diffuse large B cell lymphoma;  disease management;  health survey;  incidence;  outcome assessment;  paraproteinemia;  prognosis, Disease Management;  Female;  Humans;  Incidence;  Lymphoma, Large B-Cell, Diffuse;  Male;  Paraproteinemias;  Patient Outcome Assessment;  Prognosis;  Public Health Surveillance;  Rituximab"
}